Gout Management Guidelines

Introduction to Gout Management

• The American College of Rheumatology guidelines conditionally recommend starting urate-lowering therapy (ULT) during an acute flare, as it does not significantly extend flare duration or severity, and patients are highly motivated during acute attacks 1, 2
• The European League Against Rheumatism (EULAR) guidelines suggest that the traditional approach of waiting 2+ weeks after flare resolution remains acceptable 3

Urate-Lowering Therapy (ULT) Initiation and Dosing

• The American College of Rheumatology recommends starting allopurinol at ≤100 mg/day and increasing by 100 mg increments every 2-4 weeks to target serum urate <360 µmol/L for most patients, and <300 µmol/L for severe/recurrent gout 1, 3, 4, 5
• The target serum urate level for patients with recurrent gout is <300 µmol/L to facilitate faster crystal dissolution, as recommended by the European League Against Rheumatism (EULAR) 3

Mandatory Anti-inflammatory Prophylaxis

• The American College of Rheumatology strongly recommends using colchicine, NSAIDs, or low-dose corticosteroids for prophylaxis when starting ULT, and continuing prophylaxis for 3-6 months minimum 1, 2, 4, 5
• Prophylaxis for <3 months is associated with flare spikes upon discontinuation, as reported in the Annals of Internal Medicine 6

Indications for Urate-Lowering Therapy (ULT)

• The European League Against Rheumatism (EULAR) and the American College of Physicians (ACP) recommend ULT for patients with recurrent flares, polyarticular involvement, and those who have undergone joint surgery 3, 7, 8
• ULT is indicated for all patients with recurrent flares, as recommended by the European League Against Rheumatism (EULAR) and the American College of Rheumatology 3, 7, 8